✦ LIBER ✦

Targeting the endocannabinoid system in cancer therapy: A call for further research

✍ Scribed by Bifulco, Maurizio; Di Marzo, Vincenzo

Book ID: 109928683
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 188 KB
Volume: 8
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm0602-547

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Research progress in the use of drugs fo

Research progress in the use of drugs for breast cancer targeted therapy

✍ Yang, Shun’e ;Zhao, Bing 📂 Article 📅 2008 🏛 Springer-Verlag ⚖ 247 KB

Endocannabinoids as mediators in the hea

Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?

✍ C Robin Hiley; William R Ford 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 76 KB

Gene therapy for human prostate cancer.

Gene therapy for human prostate cancer. Translational research in the hormone refractory dunning prostate cancer model

✍ Michael A. Carducci; Sujatha R. Ayyagari; Martin G. Sanda; Jonathan W. Simons 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 833 KB

The urokinase plasminogen activator syst

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

✍ Ross W. Stephens; Nils Brünner; Fritz Jänicke; Manfred Schmitt 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 956 KB

Prospects for Targeting Protein Kinase C

Prospects for Targeting Protein Kinase C Isozymes in the Therapy of Drug-resistant Cancer – An Evolving Story

✍ Catherine A. O'Brian; Nancy E. Ward; Jubilee R. Stewart; Feng Chu 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 56 KB

The differentiation antigen NY-BR-1 is a

The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer

✍ Inka Seil; Claudia Frei; Holger Sültmann; Shirley K. Knauer; Knut Engels; Elke J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 976 KB

## Abstract Antibody‐based cancer immunotherapy relies on the identification and characterization of target antigens and the development of potent antibodies recognizing the target. Here we report the expression analysis and molecular characterization of the differentiation antigen NY‐BR‐1, which w